Galantamine Hydrobromide Sustained Release Tablets

1. This product is a cholinesterase inhibitor and can pass through the blood-brain barrier. 2. Pharmacological efficacy tests have shown that this product has a promoting effect on the acquisition of passive avoidance behavior in mice and has a significant improvement on the memory consolidation disorder caused by scopolamine and sodium nitrite. 3. It has a good promoting effect on the learning and memory reproduction of the light-dark discrimination conditioned reflex in rats.

tablet.

This product is suitable for benign memory disorders, improving patients' ability of directed memory, associative learning, image recall, meaningless pattern recognition and portrait recall, etc. It also has an improving effect on memory disorders caused by dementia patients and organic brain lesions.

Oral use, as directed by your doctor.

Not yet clear.

1. It is contraindicated for patients who are allergic to any of the ingredients in this product; 2. Galantamine is a cholinesterase inhibitor and is contraindicated under anesthesia; 3. It is contraindicated for patients with angina pectoris and bradycardia; 4. It is contraindicated for patients with severe asthma or pulmonary dysfunction; 5. It is contraindicated for patients with severe liver damage; 6. It is contraindicated for patients with severe kidney damage; 7. It is contraindicated for patients with mechanical intestinal obstruction.

Precautions for children: Children should take the drug under the guidance of a physician. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

1. This product has the potential to weaken the therapeutic effect of anticholinergic drugs. 2. It has a synergistic effect when used in combination with cholinergic drugs and other cholinesterase inhibitors. 3. This product can be used in combination with cimetidine and ketoconazole to increase its bioavailability. 4. It can be used in combination with erythromycin to reduce the efficacy of this product. 5. It has been reported that atrioventricular conduction block may occur when this product is used in combination with digoxin.

seal.

10mg

36 months

Sinopharm Yibin Pharmaceutical Co., Ltd.

• Founded in:

  1999-08-18

• Address:

  No. 1, Binjiang East Road, Luolong Industrial Concentration Zone, Yibin

• Tax NO.:

  91511500709060705C

• Registered Funds:

  33.3739 million yuan

• Website:

  Log in to view

• Email:

  Log in to view